Nucro-Technics

Scarborough, Canada Founded: 1970 • Age: 56 yrs Acquired By Frontage Laboratories
Full-service bioanalytical CRO offering toxicity, bioanalytical and stability study services

About Nucro-Technics

Nucro-Technics is a Healthcare company based in Scarborough (Canada) founded in 1970, and was acquired by Frontage Laboratories in August 2023. It operates as a full-service bioanalytical CRO offering toxicity, bioanalytical and stability study services. Nucro-Technics offers products and services including Analytical Chemistry Testing, Microbiology Testing, Toxicology Services, and Bioanalytical Services. Its focus areas include Biopharma Outsourcing, CRO, Diversified and Bioanalytical Services. Its legal entity is Nucro-Technics Inc. Its competitors include BioAgilytix, Advion, Tentamus, Nordic Bioscience and Alderley Analytical and 5 more; 3 of its 10 listed competitors have raised funding.

Company details

Nucro-Technics was founded in 1970 and is based in Scarborough, Canada. Contract research and development services are offered to the pharmaceutical, biotechnology, and medical device sectors. These include analytical chemistry, bioassay studies, genetic toxicology, bioanalytical assays, microbiology, and stability testing. Regulatory support is also provided, along with services for natural health products. Logistics, quality control, and quality assurance are handled for preclinical and clinical drug development.

  • Headquarters Scarborough, Canada
  • Stage Acquired
  • Sectors
    Healthcare
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website nucro-technics.com
  • Social LinkedIn
  • Acquired by Frontage Laboratories (Aug 2023)
  • Legal Name Nucro-Technics Inc.
Key Metrics

Products & Services of Nucro-Technics

Nucro-Technics offers a comprehensive portfolio of products and services, including Analytical Chemistry Testing, Microbiology Testing, Toxicology Services, and Bioanalytical Services.

Analytical Chemistry Testing
Laboratory Services

Performs assays for impurities and spectra in pharmaceuticals.

Microbiology Testing
Microbial Analysis

Conducts enumeration and endotoxin tests for safety compliance.

Toxicology Services
Toxicity Assessment

Evaluates dermal and oral toxicity in pre-clinical studies.

Bioanalytical Services
Bioanalysis

Provides sampling and protein-specific testing for drugs.

Funding Insights of Nucro-Technics

  • Total Rounds 1

All 1 funding rounds of Nucro-Technics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2019–Grant––
–
Valuation history

1 investors in total: 1 institutional.

Investors in Nucro-Technics

Nucro-Technics has secured backing from 1 investor. Prominent investors backing the company include Frontage Laboratories.

All
InvestorDescriptionFounded YearDomainLocation
Early drug development services are provided for pharma firms.
2001frontagelab.comExton, United States
Premium access

Investor details for Nucro-Technics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Nucro-Technics

9 people are tracked at Nucro-Technics (2 in leadership, 7 in team).

NameRoleGroup
John C. Fanaras
PresidentLeadership
Aimin Tan
Director, Bioanalytical LaboratoryLeadership
Scott Chen
MicrobiologistTeam
Igor Tsvetkov
Sr. Analytical ChemistTeam
Jeffrey Lee
Chemistry Lab AnalystTeam
Alice Liang
Hplc/gc ChemistTeam
Consy Perez
Research ScientistTeam
Diana Lozano
Microbiology AnalystTeam
Mandeep Singh
Team Leader-mass SpectrometryTeam
Premium access

Complete people profiles for Nucro-Technics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Nucro-Technics

3 dated milestones of Nucro-Technics across 53 years, from founding to its latest funding, stage changes and deals.

  1. Founded Nucro-Technics is founded.
  2. Funding First funding round.
  3. Exit Acquired by Frontage Laboratories.

Competitors of Nucro-Technics

Nucro-Technics has 10 listed competitors in our database, 3 of them funded. They include BioAgilytix, Advion, Tentamus, Nordic Bioscience and Alderley Analytical, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
bioagilytix.com2008Durham, United States–446
Large-molecule bioanalysis is provided for biologics and biosimilars development.
advion.com1993Ithaca, United States$45.64M54
Microfluidics and mass spectrometry products are provided for clinical research.
tentamus.com2011Berlin, Germany–368
Analytical and quality assurance services are provided for diverse industries.
nordicbioscience.com1996Herlev, Denmark–178
Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform
alderleyanalytical.com2013Stockport, United Kingdom$869,35241
Bioanalytical assays for drug development are developed and validated.
eag.com1978San Diego, United States–601
Company offering a suite of scientific services for materials, engineering, agri, and life science industries
nuvisan.com1979Neu Ulm, Germany–1,011
Clinical trial supply and bioanalytical services are provided globally.
lightcast.bio2019Cambridge, United Kingdom$107.09M25
Advanced single-cell analysis solutions are provided for biotechnology research.
apocell.com2004Houston, United States–2,198
Provider of clinical trial and clinical development on bioanalytical services
solvias.com1999Kaiseraugst, Switzerland––
Integrated R&D services are provided for pharmaceuticals and allied sectors.
Premium access

Detailed competitors of Nucro-Technics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Nucro-Technics

The website of Nucro-Technics (nucro-technics.com) receives about 1.1K visits a month.

  • Monthly visits
    1.1K

    ▲ 97.2% vs previous month

Similar websites

Websites whose visitors overlap most with Nucro-Technics. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
acmgloballab.com
100%
9.2K#2,731,952View details
inc-cro.co.jp
inc-cro.co.jp
100%
–––
cmocro.com
100%
21.8K#1,242,657View details
neclife.com
99%
4.6K#4,844,386View details
jnjinnovation.com
jnjinnovation.com
99%
–#763,010–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 7 similar websites and full traffic analytics for Nucro-Technics

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 7 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

10 companies that operate in the same segment as Nucro-Technics (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M1,820
Drug discovery and development services are provided to biopharma sector.
1993Hamburg, Hamburg, GermanyUSD 25 MUSD 926.33 M4,830
Drug discovery and development services for small molecules are provided.
2003Beijing, ChinaUSD 320 M–476
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M4,490
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M12,470
Pharmaceutical products for treating multiple diseases are provided.
1849New York, New York, United StatesUSD 8 MUSD 266.99 M1,770
Provider of laboratory tests for physicians
1969Burlington, Vermont, United States–USD 13.95 B70,000
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M4,260
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Nucro-Technics

Premium access

Complete news archive for Nucro-Technics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nucro-Technics

Nucro-Technics was founded in 1970 and raised its 1st funding round 49 years after it was founded.

Nucro-Technics is headquartered in Scarborough, Canada. It is registered at Scarborough, Ontario, Canada.

Nucro-Technics was founded in 1970 and is based in Scarborough, Canada. Contract research and development services are offered to the pharmaceutical, biotechnology, and medical device sectors. These include analytical chemistry, bioassay studies, genetic toxicology, bioanalytical assays, microbiology, and stability testing. Regulatory support is also provided, along with services for natural health products. Logistics, quality control, and quality assurance are handled for preclinical and clinical drug development.

Nucro-Technics's top competitors include Alderley Analytical, BioAgilytix and Lightcast Discovery.

Nucro-Technics offers Analytical Chemistry Testing, Microbiology Testing, Toxicology Services, and Bioanalytical Services.

Nucro-Technics has 1 investor. Key investors include Frontage Laboratories.

Nucro-Technics operates through Nucro-Technics Inc..

Yes. Nucro-Technics was acquired by Frontage Laboratories in August 2023.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available